Cardiotoxicity in Breast Cancer – Case Discussion

University of Colorado Department of Medicine

L. Kondapalli

Cardio-Oncology: Definitions and Scope

University of Colorado Department of Medicine

L. Kondapalli

How to Minimize and Manage Checkpoint Inhibitors Adverse Cardiac Eve…

University of Colorado Department of Medicine

L. Kondapalli

The PRONOUNCE and HERO Trials: The Cardiovascular Safety of Degareli…

Przemyslaw Twardowski

How the Experts Manage: Cardiotoxicity and IO in NSCLC

MI&T Congressi

J. Remon Masip

ADT for Prostate Cancer and Cardiovascular Health Considerations

Andrew Hahn

Cardio-Oncology in Breast Cancer: Treatment Options for Anthracyclin…

Total Health

I. Rhea

Cardiotoxicity in Melanoma – Case Discussion

University of Colorado Department of Medicine

L. Kondapalli

Cardiotoxicity in RCC – Case Discussion

University of Colorado Department of Medicine

L. Kondapalli

Cardiac Disease in Breast Cancer: Background & Risk Factors

Total Health

I. Rhea

Using Cytoreductive Therapy to Prevent Cardiovascular Events in Pati…

Monia Marchetti

Clinical Presentation of Amyloidosis: Who to Suspect? - a 2022 Update

Scripps Health

R. Mohan

Cardio-Oncology in Breast Cancer: Treatment Options for Immune Check…

Total Health

I. Rhea

Cancer and Cardiovascular Disease: The Conjoined Twins

MedNews Week

R. Moudgil

General Approach to Cardio-Oncology in Breast Cancer

Total Health

I. Rhea

Cardio-Oncology: The Interplay of Immunotherapy, Inflammation, and C…

UCLA Health

E. Yang

Role of Multimodality Imaging in Cardio-Oncology

Scripps Health

P. Parwani

2024 Updates on Carcinoid Heart Disease

North American Neuroendocrine Tumor Society

A. Nohria

Why the Heart Matters: Cardio-Oncology for Breast Health Outcomes

NYU Langone

A. Fadol

Cancer Survivorship: How To Monitor for Cardiac Disease Following Tr…

Scripps Health

A. Kuo